PMID: 8949658Sep 1, 1996Paper

Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients

Gut
A J StanleyP C Hayes

Abstract

Transjugular intrahepatic portosystemic stent shunts (TIPSS) are increasingly being used to manage the complications of portal hypertension. This study reports on the follow up on 130 patients who have undergone TIPSS. One hundred and thirty patients (81 male), mean (SD) age 54.7 (12.5) years underwent TIPSS. The majority (64.6%) had alcoholic cirrhosis and 53.2% had Childs C disease. Indications were: variceal haemorrhage (76.2%), refractory ascites (13.1%), portal hypertensive gastropathy (4.6%), others (6.1%). Shunt function was assessed by Doppler ultrasonography and two then six monthly portography and mean follow up for survivors was 18.0 months (range 2-43.5). The procedure was successful in 119 (91.5%). Sixty three episodes of shunt dysfunction were observed in 45 (37.8%) patients. Variceal rebleeding occurred in 16 (13.4%) patients and was always associated with shunt dysfunction. Twenty (16.8%) patients had new or worse spontaneous encephalopathy after TIPSS and 11 (64.7%) patients had an improvement in resistant ascites. Thirty day mortality was 21.8% and one year survival 62.5%. TIPSS is an effective treatment for variceal bleeding, resistant ascites, and portal hypertensive gastropathy. Rebleeding is invariably ass...Continue Reading

References

Apr 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M LacyJ Terés
Jun 4, 1992·The New England Journal of Medicine·G V StiegmannS R Lowenstein
Jun 1, 1990·Cardiovascular and Interventional Radiology·G M RichterM Roessle
Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D WestabyR Williams
May 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H Licht, A Mermelstein
Oct 1, 1984·World Journal of Surgery·J M HendersonW D Warren
May 4, 1995·The New England Journal of Medicine·A OchsH E Blum
Apr 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J QuirogaJ Prieto
Jun 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M C HouS D Lee
Oct 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J Sanyal
Jul 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W B OffenspergerD Häussinger
Jul 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J SanyalA K Cheatham
Jan 20, 1994·The New England Journal of Medicine·M RössleK Hauenstein
Jan 20, 1994·The New England Journal of Medicine·N D Grace
Mar 1, 1993·Journal of Vascular and Interventional Radiology : JVIR·M Y PeltzerR L Gordon
Jan 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas D BoyerUNKNOWN American Association for the Study of Liver Diseases

❮ Previous
Next ❯

Citations

Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J SanyalM F Graham
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J Sanyal, F Mirshahi
Sep 1, 2006·Current Treatment Options in Gastroenterology·Riccardo A Superina, Estella M Alonso
Jun 7, 2011·Abdominal Imaging·Capucine MicolAgnès Rode
May 27, 2006·Cardiovascular and Interventional Radiology·A QuateenJ Ricke
May 24, 2000·Cardiovascular and Interventional Radiology·R J Owen, J D Rose
Jun 17, 1998·Cardiovascular and Interventional Radiology·R JalanD N Redhead
Jun 17, 1998·Cardiovascular and Interventional Radiology·J LatimerJ D Rose
Dec 20, 2000·Transplantation Proceedings·A K ChuiA G Sheil
Jul 20, 2000·The Australian and New Zealand Journal of Surgery·A K ChuiA G Sheil
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bernhard AngermayrUNKNOWN Vienna TIPS Study Group
Jul 4, 1998·Lancet·A J Stanley, P C Hayes
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Steven W M Olde DaminkPeter B Soeters
Apr 11, 2001·European Journal of Gastroenterology & Hepatology·S H ShahP C Hayes
Apr 21, 2004·European Journal of Gastroenterology & Hepatology·Dhiraj TripathiPeter C Hayes
Oct 11, 2005·European Journal of Gastroenterology & Hepatology·Ramasamy SaravananMartin G Lombard
Nov 9, 2007·Digestive Diseases and Sciences·Sharad SharmaNicolas Jabbour
Aug 22, 2013·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Ilia GurSusan L Orloff
Jun 10, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Ahmed HelmyPeter C Hayes
Jun 23, 2001·The American Journal of Gastroenterology·M DelhayeP Galand
Nov 26, 2003·The American Journal of Gastroenterology·Darius SorbiAlan R Zinsmeister
Feb 7, 2006·European Urology·Andrea MinerviniAnthony G Timoney
Oct 5, 2001·Vascular Surgery·H Abu-JudehK G Swan
Jul 6, 2004·The American Journal of Gastroenterology·Joel H RubensteinJohn M Inadomi
May 13, 1999·Postgraduate Medical Journal·N H PatelR M Jindal
Dec 17, 2008·Alimentary Pharmacology & Therapeutics·N KocharP C Hayes
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·S H SongP C Butler
Jan 30, 2021·Journal of Translational Internal Medicine·Andrea GalloAlessandro Squizzato
Jun 3, 2000·Gastroenterology Clinics of North America·V A Luketic, A J Sanyal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.